Related Experiment Video
Updated: Apr 6, 2026
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
Immune Infiltration and Prostate Cancer
1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California San Diego School of Medicine , La Jolla, CA , USA ; Laboratory of Gene Regulation and Signal Transduction, Department of Pathology, University of California San Diego School of Medicine , La Jolla, CA , USA.
Inflammation and immune cells significantly impact prostate cancer (PCa) progression. Understanding specific immune profiles is crucial for optimizing immunotherapy effectiveness and patient outcomes in PCa treatment.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Inflammation plays a key role in prostate cancer (PCa) development.
- Immune cells are primary drivers of inflammation-associated PCa.
- Current immunotherapy trials show promise but lack complete response rates.
Purpose of the Study:
- To review the role of inflammation and immune cells in PCa progression.
- To identify optimal immunotherapy targets, regimens, and response predictors.
- To highlight areas for future research in PCa immunotherapy.
Main Methods:
- Literature review of current knowledge on inflammation and PCa.
- Analysis of immune cell subsets and their role in tumor microenvironment.
- Summary of ongoing clinical trials for PCa immunotherapy.
Main Results:
- The precise immune profile dictating clinical outcomes in PCa is not yet fully understood.
- Different immune cell subsets have varying effects on tumor development.
- The tumor microenvironment significantly influences immune cell function.
Conclusions:
- Further research is needed to elucidate specific immune profiles for effective PCa immunotherapy.
- Optimizing immunotherapy requires a deeper understanding of inflammation's role.
- Identifying predictive biomarkers for immunotherapy response is critical for PCa patients.
